Join Now

Yearly Archives: 2021

Co-Diagnostics Reports Continued Strength in Third Quarter 2021 Financial Results

By Natalie Themm | Published November 17, 2021

Solid quarterly results highlighted by record revenue of $30.1 million, pre-tax income of $13.6 million and fully diluted EPS of $0.38

Posted in BioUtah News | Tagged , | Leave a comment

SDP Oncology Announces First Patient Dosed in Phase 1 Dose Expansion Study of TP-1287 in Patients with Sarcoma

By Denise Bell | Published November 11, 2021

Sumitomo Dainippon Pharma Oncology (SDP Oncology), which has research facilities in Lehi, Utah, recently announced that the first patient has been dosed in the Phase 1 dose expansion portion of the study evaluating the investigational agent TP-1287, an oral cyclin-dependent kinase 9 (CDK9) inhibitor, in patients with sarcoma. “Patients with sarcoma currently face a significant […]

Posted in Policy News | Leave a comment

State Legislature Passes Statute regulating mandatory vaccination policies in the workplace.

By Natalie Themm | Published November 10, 2021

The Utah legislature convened in special session this week regarding the issuance of an OSHA Emergency Temporary Standard (ETS) requiring the vaccination of all employees of companies with more than 100 employees.

Posted in BioUtah News | Leave a comment

AdvaMed Statement on Administration’s COVID-19 Testing Policy for Employers

By Natalie Themm | Published November 10, 2021

AdvaMed released a statement from AdvaMedDx Executive Director Susan Van Meter on the testing policy regulation recently proposed by the Occupational Safety and Health Administration (OSHA) for employers with 100 or more employees under the Administration’s vaccine mandate.

Posted in BioUtah News | Tagged | Leave a comment

PolarityTE Reports Third Quarter Financial Results and Provides Business Update

By Natalie Themm | Published November 10, 2021

PolarityTE, Inc. recently provided a business update and reported financial results for the three and nine-month periods ended September 30, 2021.

Posted in BioUtah News | Tagged | Leave a comment

Renalytix Convenes Expert Panel at VA Healthcare Summit

By Natalie Themm | Published November 10, 2021

Leading clinicians discuss enabling long-term kidney health in Veterans with type 2 diabetes and early-stage chronic kidney disease

Posted in BioUtah News | Tagged | Leave a comment

St. Joseph’s Health and Renalytix Partner to Advance Value-Based Kidney Health in New York

By Natalie Themm | Published November 9, 2021

Partnership expands doctor and patient access to advanced prognosis and coordinated care management of early-stage diabetic kidney disease

Posted in BioUtah News | Tagged | Leave a comment

U.S. Department of Labor’s Occupational Safety and Health Administration Unveils Rule to Mandate COVID-19 Vaccines for Large Employers

By Denise Bell | Published November 4, 2021

The Department of Labor’s Occupational Safety and Health Administration (OSHA) yesterday issued a rule requiring employers with 100 or more employees to enforce a mandatory COVID-19 vaccination policy, unless they adopt a policy requiring employees to choose to either be vaccinated or undergo regular COVID-19 testing and wear a face covering at work. The rule, […]

Posted in COVID-19 Updates, Policy News | Leave a comment

Sumitomo Dainippon Pharma Oncology Announces First Patient Dosed in Phase 1 Study of DSP-0390 in Patients with Recurrent High-Grade Glioma 

By Denise Bell | Published November 4, 2021

Sumitomo Dainippon Pharma Oncology (SDP Oncology), which has research facilities in Lehi, Utah, recently announced that the first patient has been dosed in a Phase 1 study evaluating its investigational agent DSP-0390, an emopamil-binding protein (EBP) inhibitor, for the treatment of patients with recurrent high-grade glioma. “Dosing the first patient in this study represents another […]

Posted in BioUtah News, Industry News, Utah's Life Sciences Companies | Leave a comment

Co-Diagnostics, Inc. Logix Smart™ COVID-19 2-Gene Test Approved for Use in the United Kingdom

By Natalie Themm | Published November 4, 2021

Company’s validated test available in the UK following implementation of UKHSA CTDA Regulations

Posted in BioUtah News | Tagged , | Leave a comment

New report shows more than 260 medicines in development to fight neurodegenerative diseases

By Natalie Themm | Published November 3, 2021

PhRMA released a new report detailing the more than 260 medicines in development for 29 neurodegenerative diseases

Posted in BioUtah News | Tagged | Leave a comment

Clene Nanomedicine Announces Top-Line Results from Phase 2 RESCUE-ALS Clinical Trial

By Natalie Themm | Published November 3, 2021

Clene recently announced top-line data from RESCUE-ALS, a Phase 2 clinical trial evaluating CNM-Au8 as a disease modifying treatment for people with early amyotrophic lateral sclerosis (ALS).

Posted in BioUtah News | Tagged , | Leave a comment

A Special Thanks To Our Legacy and Platinum Elite Members